These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 4862960)

  • 1. Behavioral effects of diphenylhydantoin in severe psychiatric disorders.
    Klein DF; Greenberg IM
    Am J Psychiatry; 1967 Dec; 124(6):847-9. PubMed ID: 4862960
    [No Abstract]   [Full Text] [Related]  

  • 2. EEG spikes in non-epileptic psychiatric patients.
    Small JG; Small IF
    Dis Nerv Syst; 1967 Aug; 28(8):523-5. PubMed ID: 6048415
    [No Abstract]   [Full Text] [Related]  

  • 3. Clinical studies with propericiazine (R.P. 8909).
    St Jean A; Sterlin C; Noe W; Ban TA
    Dis Nerv Syst; 1967 Aug; 28(8):526-31. PubMed ID: 4383004
    [No Abstract]   [Full Text] [Related]  

  • 4. The psychoactive properties of diphenylhydantoin: experiences with prisoners and juvenile delinquents.
    Resnich O
    Int J Neuropsychiatry; 1967 Dec; 3():Suppl 2:30-6. PubMed ID: 4873471
    [No Abstract]   [Full Text] [Related]  

  • 5. The usefulness of diphenylhydantoin in treatment of non-epileptic emotional disorders.
    Turner WJ
    Int J Neuropsychiatry; 1967 Dec; 3():Suppl 2:8-20. PubMed ID: 5587569
    [No Abstract]   [Full Text] [Related]  

  • 6. Comprehesiven clinical studies with thiothixene.
    Ban TA; Lehmann HE; Sterlin C; Climan M
    Dis Nerv Syst; 1975 Sep; 36(9):473-7. PubMed ID: 240651
    [No Abstract]   [Full Text] [Related]  

  • 7. [Therapeutic experiences with oxazepam--a derivative of the benzodiazepine series--in child and adolescent psychiatry].
    Nievoll A
    Wien Klin Wochenschr; 1971 Apr; 83(14):251-4. PubMed ID: 5559790
    [No Abstract]   [Full Text] [Related]  

  • 8. Chlorpromazine-chlordiazepoxide and chlorpromazine-imipramine treatment of newly hospitalized, acutely ill psychiatric patients.
    Michaux MH; Kurland AA; Agallianos DD
    Curr Ther Res Clin Exp; 1966 Mar; 8(3):Suppl:117-52. PubMed ID: 4956162
    [No Abstract]   [Full Text] [Related]  

  • 9. Concurrent administration of phenobarbital and diphenylhydantoin: lack of an interference effect.
    Booker HE; Tormey A; Toussaint J
    Neurology; 1971 Apr; 21(4):383-5. PubMed ID: 5102870
    [No Abstract]   [Full Text] [Related]  

  • 10. [Indications for the use of neuleptil. Review of the literature and clinical contribution].
    Catalano A; Del Pistoia L; De Risio C; Ridolo P
    Riv Sper Freniatr Med Leg Alien Ment; 1967; 91():Suppl 5:1307+. PubMed ID: 4388059
    [No Abstract]   [Full Text] [Related]  

  • 11. Early clinical drug evaluation units reports.
    Psychopharmacol Bull; 1972 Jan; 8(1):60-72. PubMed ID: 4554930
    [No Abstract]   [Full Text] [Related]  

  • 12. Some effects of mesoridazine (TPS-23) on chronic psychiatric patients.
    Douglas KW; Hindley JP; Kerin MT
    Dis Nerv Syst; 1967 Feb; 28(2):113-7. PubMed ID: 6021590
    [No Abstract]   [Full Text] [Related]  

  • 13. [Studies of the effect of 5,5-diphenylhydantoin on the bioelectric activity of the brain in epilepsy].
    Domzal T; Gajkowski K
    Neurol Neurochir Pol; 1971; 5(3):301-6. PubMed ID: 5000628
    [No Abstract]   [Full Text] [Related]  

  • 14. Neulactil (pericyazine) in the behaviour disturbances of institutionalized mental defectives.
    Daneel AB
    S Afr Med J; 1967 Oct; 41(39):995-8. PubMed ID: 6081157
    [No Abstract]   [Full Text] [Related]  

  • 15. A quantitative study of the acute effects of diphenylhydantoin on the electroencephalogram of epileptic patients. Theoretical considerations for its use in the treatment of status epilepticus.
    Riehl JL; McIntyre HB
    Neurology; 1968 Nov; 18(11):1107-12. PubMed ID: 5751917
    [No Abstract]   [Full Text] [Related]  

  • 16. ACNP--session on diphenylhydantoin: introductory remarks.
    Elkes J
    Int J Neuropsychiatry; 1967 Dec; 3():Suppl 2:6-7. PubMed ID: 5587568
    [No Abstract]   [Full Text] [Related]  

  • 17. An evaluation of the permanence of the "tardive dyskinesias".
    Paulson GW
    Dis Nerv Syst; 1968 Oct; 29(10):692-4. PubMed ID: 5717285
    [No Abstract]   [Full Text] [Related]  

  • 18. Diphenylhydantoin in emotional disorders.
    Livingston S
    JAMA; 1968 May; 204(6):549. PubMed ID: 5694442
    [No Abstract]   [Full Text] [Related]  

  • 19. Diphenylhydantoin-induced asterixis. A clinical study.
    Murphy MJ; Goldstein MN
    JAMA; 1974 Jul; 229(5):538-40. PubMed ID: 4406897
    [No Abstract]   [Full Text] [Related]  

  • 20. One-year study of fluphenazine enanthate.
    Hsu JJ; Nol E; Martinez ML; Lessien B; Paragas PG; Puhac M; Braun RA
    Dis Nerv Syst; 1967 Dec; 28(12):807-11. PubMed ID: 4864388
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.